Morning Briefing
Summaries of health policy coverage from major news organizations
WHO, Wyeth Launch Trial In Africa To Test New River Blindness Drug
The WHO on Wednesday announced plans for a clinical trial to test a new drug that "could halve the treatment period for river blindness [or onchocerciasis], a disease that threatens 100 million people mostly in Africa," AFP/CNN Money reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
